Login
Products
Login
Home
Alerts
Search
Watchlist
Products

M K Proteins Ltd

MKPL
NSE
5.31
0.75%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

M K Proteins Ltd

MKPL
NSE
5.31
0.75%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
199Cr
Close
Close Price
5.31
Industry
Industry
Solvent Extraction
PE
Price To Earnings
24.14
PS
Price To Sales
0.53
Revenue
Revenue
374Cr
Rev Gr TTM
Revenue Growth TTM
72.12%
PAT Gr TTM
PAT Growth TTM
-25.72%
Peer Comparison
How does MKPL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MKPL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
761469875734391371153290
Growth YoY
Revenue Growth YoY%
-24.8147.0-42.757.9100.5-3.7126.8
Expenses
ExpensesCr
721365785431381331093187
Operating Profit
Operating ProfitCr
41484225612
OPM
OPM%
5.34.75.29.76.56.64.53.44.83.22.6
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
10000001100
Depreciation
DepreciationCr
00000000000
PBT
PBTCr
31383224512
Tax
TaxCr
10121101101
PAT
PATCr
20262213411
Growth YoY
PAT Growth YoY%
-0.4324.4-44.4-52.041.5-56.93.6
NPM
NPM%
3.33.03.66.74.35.23.52.03.02.31.6
EPS
EPS
0.10.00.10.20.10.00.00.10.10.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
145165172157194311256315246268374
Growth
Revenue Growth%
13.74.3-8.723.860.3-17.823.1-22.09.039.8
Expenses
ExpensesCr
141160166152189295240298229255361
Operating Profit
Operating ProfitCr
45655161617171214
OPM
OPM%
2.93.03.23.22.55.16.15.46.84.63.6
Other Income
Other IncomeCr
00000001000
Interest Expense
Interest ExpenseCr
22221112112
Depreciation
DepreciationCr
11111111100
PBT
PBTCr
12222141415151112
Tax
TaxCr
01111444433
PAT
PATCr
111221010111188
Growth
PAT Growth%
36.544.715.210.6471.8-2.07.42.5-25.11.1
NPM
NPM%
0.50.60.81.10.93.34.03.54.63.12.3
EPS
EPS
3.04.00.00.00.10.30.30.30.30.20.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
134444413383838
Reserves
ReservesCr
32111315253537243236
Current Liabilities
Current LiabilitiesCr
283029293434445034594
Non Current Liabilities
Non Current LiabilitiesCr
8121224534122
Total Liabilities
Total LiabilitiesCr
394756475767861039613180
Current Assets
Current AssetsCr
32395042536482998611967
Non Current Assets
Non Current AssetsCr
78654345101213
Total Assets
Total AssetsCr
394756475767861039613180

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-4-4-126-46-10-632-16
Investing Cash Flow
Investing Cash FlowCr
-2-10000-20-6-1
Financing Cash Flow
Financing Cash FlowCr
6512-74-5126-2718
Net Cash Flow
Net Cash FlowCr
0000000000
Free Cash Flow
Free Cash FlowCr
-6-5-127-45-12-627-18
CFO To PAT
CFO To PAT%
-585.7-363.4-842.6386.5-246.053.3-99.4-53.7289.1-192.1
CFO To EBITDA
CFO To EBITDA%
-100.9-73.5-218.0127.7-93.334.7-64.7-34.4195.1-129.7

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0034313033800371227
Price To Earnings
Price To Earnings
0.00.023.518.916.43.27.80.032.927.4
Price To Sales
Price To Sales
0.00.00.20.20.10.10.30.01.50.8
Price To Book
Price To Book
0.00.02.21.81.61.12.00.06.13.3
EV To EBITDA
EV To EBITDA
6.16.211.911.512.53.67.52.723.521.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
10.411.18.08.47.38.111.29.411.910.5
OPM
OPM%
2.93.03.23.22.55.16.15.46.84.6
NPM
NPM%
0.50.60.81.10.93.34.03.54.63.1
ROCE
ROCE%
11.310.89.18.98.028.019.517.620.411.6
ROE
ROE%
22.123.29.29.69.635.425.721.918.412.1
ROA
ROA%
1.92.12.53.53.215.411.810.611.76.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
M. K. Proteins Limited is a vertically integrated Indian manufacturing and trading enterprise specializing in the edible oil industry. The company operates a sophisticated, mechanized refinery in **Ambala, Haryana**, producing high-quality vegetable refined oils and high-value by-products. Having successfully transitioned from the **NSE SME Emerge** platform to the **Main Board of the NSE and BSE** in **June 2023**, the company is currently scaling its operations to capture the shift from unbranded to organized branded oil consumption in India. --- ### Integrated Refining Operations and Product Portfolio The company’s business model is centered on a single reportable segment: **Manufacturing of Vegetable Refined Oil**. Its competitive advantage lies in a completely mechanized refining process that ensures sustained levels of cleaning and monitoring to produce oils with controlled fiber and protein content, free from residue and ash. * **Refined Oil Variants:** The portfolio includes **Rice Bran Oil, Sunflower Oil, Canola Oil, Soya Bean Oil,** and **Rice Bran Bleached Oil**. * **By-product Commercialization:** The refining process yields several salable by-products, including **Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums, and Spent Earth**, which contribute to diversified revenue streams. * **Trading and Import Capabilities:** Beyond manufacturing, the company imports crude oils for internal processing and engages in the trading of both edible and non-edible oils to meet domestic demand. In **FY23**, the CIF value of imports stood at **Rs. 2,520.56 Lakhs**. * **Geographic Focus:** The company is currently **100% domestic-focused**, reporting **zero export earnings** for the **2021-22** and **2022-23** periods. --- ### Strategic Growth Initiatives and Capital Expenditure To maintain its market position in a fragmented industry, M. K. Proteins is aggressively investing in technology and distribution. * **Technological Upgrades:** In **December 2023**, the Board approved a capital expenditure of **Rs. 5.90 Crores** for new **Vegetable Oil Refinery Equipment** to enhance final product quality and operational efficiency. * **Market Expansion:** The company is targeting the **13%** of the Indian market still using unbranded/loose oil. Strategy involves improving direct coverage in rural India, which accounts for nearly **50%** of category volume. * **Operational Resilience:** Despite price volatility in early **2023**, the company revived volumes in **H2 2023** by capitalizing on increased out-of-home consumption during India’s festival and wedding seasons. * **Cost Efficiency:** The company utilizes indigenous technology to lower production costs and supplements government electricity with internal generation. --- ### Financial Performance and Capital Structure M. K. Proteins has demonstrated a commitment to shareholder value through aggressive corporate actions and capital restructuring. **Key Financial Metrics** | Particulars (Rs. in Crore) | FY 2024-25 | FY 2023-24 | | :--- | :--- | :--- | | **Operational Revenue** | **268.18** | **246.02** | | **Profit Before Tax (PBT)** | **11.45** | **15.47** | | **Net Profit (PAT)** | **8.39** | **11.21** | | **Total Equity** | **69.47** | **61.08** | | **Total Debt** | **37.75** | **19.09** | | **Debt-Equity Ratio** | **0.54** | **0.31** | **Capital Restructuring History** * **Stock Split (Nov 2023):** Sub-division of face value from **Rs. 10** to **Re. 1** per share to enhance liquidity. * **Bonus Issue (March 2024):** Allotment of **25,02,48,000** shares in a **2:1** ratio. This followed a previous **2:1** bonus in **February 2023**. * **Authorized Capital:** Increased from **Rs. 15 Crores** to **Rs. 40 Crores** in **March 2024** to accommodate growth. * **Paid-up Capital:** Currently stands at **Rs. 37,53,72,000** (comprising **37,53,72,000** shares). --- ### Governance, Management, and Oversight The company is managed by the **Kumar brothers** (**Parmod, Vinod, Parvind, and Raj Kumar**), who bring decades of industry experience. * **Board Structure:** As of **March 31, 2025**, the board consists of **8 Directors**, including **4 Independent Directors**. * **Key Leadership:** **Mr. Parmod Kumar** serves as the **Managing Director** and **Chief Operating Decision Maker (CODM)**. * **Recent Appointments:** **Mr. Deepak Khetarpal** joined as an Independent Director in **August 2025**. * **Auditor Transition:** In **August 2025**, the company transitioned from **M/s. KRA & Co.** to a local statutory audit firm to improve operational coordination and ensure timely regulatory compliance. --- ### Risk Framework and Mitigation Strategies The edible oil sector is characterized by high volatility and regulatory sensitivity. M. K. Proteins manages these through a structured risk framework. **1. Commodity and Supply Chain Risks** * **Price Volatility:** A **1% increase** in commodity prices impacts profits by approximately **Rs. 2.72 Crores**. * **Import Dependency:** India imports **1.6 crore metric tonnes** annually. The company is vulnerable to export policy shifts in **Indonesia and Malaysia**. * **Climate Sensitivity:** Domestic oilseed production is **76% rain-fed**. In **July 2023**, extreme rainfall (**500mm**) caused a **19-day** operational shutdown at the Ambala facility due to flooding. **2. Financial and Liquidity Risks** * **Debt Management:** Current borrowings of **Rs. 36.92 Crore** (as of March 2025) are primarily **Secured Cash Credit Facilities** from **HDFC Bank** at interest rates of **9% to 9.23%**. * **Interest Rate Sensitivity:** A **50 bps** change in rates impacts profit by **Rs. 9.54 Lakhs**. * **Credit Risk:** Managed via an **Expected Credit Loss (ECL)** model and a focus on **advance payments**. **3. Sectoral Challenges** * **Regulatory Shifts:** Profitability is tied to the **Government of India’s** duty differentials between crude and refined oils and changes in **Minimum Support Prices (MSP)**. * **Industry Inefficiencies:** The sector broadly suffers from **low capacity utilization** and **outdated technology**, which the company seeks to bypass through its mechanized refinery model. --- ### Market Outlook The Indian branded edible oil market is valued at **Rs. 1,56,000 Crores** and is projected to reach a **90%** value share of the total market within five years. With global edible oil markets expected to reach **USD 190.88 Billion** by **2030** (**8.10% CAGR**), M. K. Proteins is positioned to leverage its increased capital base and modernized refining capacity to capture domestic volume growth.